Intrauterine Embryo Development With ANECOVA Device

Phase 3

Terminated

• Conditions: Healthy

• Registration Number: NCT00480103
• Lead Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA

Brief Summary

We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-05-28
• Study First Submitted QC: 2007-05-29
• Study First Posted: 2007-05-30
• Study Start: 2007-08
• Primary Completion: 2008-11
• Study Completion: 2008-11
• Status Verified: 2011-03
• Last Update Submitted: 2011-03-03
• Last Update Posted: 2011-03-04

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Women age below 37
• Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)
• Negative serologic screening for HIV, Hep B and C
• No uterine or ovarian alterations found by ultrasound
• Normal BMI (19 - 29 kg/m2).

Exclusion Criteria

• At least 8 stage MII oocytes are not retrieved
• Endometriosis or PCO
• Severe male factor in the partner

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Instituto Valenciano de Infertilidad Spain; 🇪🇸 Valencia, Spain